Mallardo, D., Giannarelli, D., Vitale, M. G., Galati, D., Trillò, G., Esposito, A., Isgrò, M. A., D'Angelo, G., Festino, L., Vanella, V., Trojaniello, C., White, A., De Cristofaro, T., Bailey, M., Pignata, S., Caracò, C., Petrillo, A., Muto, P., Maiolino, P., Budillon, A., Warren, S., Cavalcanti, E., & Ascierto, P. A. (2022). nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis. Journal for immunotherapy of cancer, 10(11), . http://access.bl.uk/ark:/81055/vdc_100170101903.0x00000d